Skip to content
Certified ManufacturersFor manufacturers

Mineralife Nutraceuticals, LLC

Colorado Springs, CO, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Mineralife Nutraceuticals, LLC is a dietary supplement manufacturer in Colorado Springs, CO, United States, certified to NSF/ANSI 455-2 GMP, with 2 manufacturing facilities on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, liquids and powders.

Facilities listed
2
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (2)

  • 1435 Woolsey Heights, Colorado Springs, CO 80915, United States

    • Dry Formulation
    • Encapsulation
    • Liquid Formulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Warehousing
  • 1459 Woolsey Heights, Colorado Springs, CO 80915, United States

    • Quality Unit Operations
    • Warehousing

How Mineralife Nutraceuticals, LLC compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

No food or dietary supplement recall found under the name Mineralife Nutraceuticals, LLC in FDA’s enforcement reports, as of .

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 3 food or dietary supplement inspections at facilities matching Mineralife Nutraceuticals, LLC, from 2019 to 2025, as of . All 3 found conditions the firm was left to correct.

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Colorado Springs, Colorado

    8 citations posted:

    • Specifications - components (21 CFR 111.70(b))
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
    See all 8 citations
    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications, necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met and limits on contamination to ensure the quality of the dietary supplement.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for purity and limits on contamination.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    • Tests, examinations - scientifically valid (21 CFR 111.75(h))

      You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.

    • Master manufacturing record - record requirements (21 CFR 111.210)

      Your master manufacturing record did not include all required information.

    • Batch record - follow master (21 CFR 111.255(c))

      Your batch production record did not accurately follow the appropriate master manufacturing record.

    • Examination, testing methods; criteria for selecting (21 CFR 111.315(c))

      You did not establish and follow laboratory control processes for use of criteria for selecting appropriate examination and testing methods.

    FEI 3008281246

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Colorado Springs, Colorado

    11 citations posted:

    • Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))
    • Document-equipment date of use, maintain, clean, sanitize (21 CFR 111.35(b)(2))
    • Specifications - component identity (21 CFR 111.70(b)(1))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    See all 11 citations
    • Procedures - equipment - cleaning, sanitizing (21 CFR 111.25(c))

      You did not establish written procedures for maintaining, cleaning, and sanitizing, equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements.

    • Document-equipment date of use, maintain, clean, sanitize (21 CFR 111.35(b)(2))

      You did not make and keep documentation of maintenance of the equipment.

    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength and composition.

    • Specifications - contamination limits (21 CFR 111.70(b)(3))

      You did not establish limits for contamination that may adulterate or may lead to adulteration of the finished dietary supplement.

    • Specifications - contamination limits (21 CFR 111.70(e))

      You did not establish product specifications for limits on contamination that may adulterate, or that may lead to adulteration of, the finished dietary supplement.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.

    • Quality control - adulteration; material review, disposition (21 CFR 111.113(a)(3))

      Your quality control personnel did not conduct a material review and make a disposition decision for an unanticipated occurrence during the manufacturing operations that adulterated or may lead to adulteration of the dietary supplement.

    • Records - material review, disposition documentation (21 CFR 111.140(b)(3))

      You did not make and keep documentation of your material review and disposition decision.

    • Master manufacturing record - specifications; quality (21 CFR 111.205(b)(1))

      Your master manufacturing record did not identify specifications for the points, steps, or stages in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.

    • Examination, testing; appropriate (21 CFR 111.320(a))

      You did not verify that the laboratory examination and testing methodologies are appropriate for their intended use.

    FEI 3008281246

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Colorado Springs, Colorado

    6 citations posted:

    • Procedures - calibrating automated, mechanical equip (21 CFR 111.25(b))
    • Specifications met - verify; finished batch (21 CFR 111.75(c))
    • Written procedures - product complaint (21 CFR 111.553)
    • Quality control, review, approve; investigate, follow-up (21 CFR 111.560(b))
    See all 6 citations
    • Procedures - calibrating automated, mechanical equip (21 CFR 111.25(b))

      You did not follow written procedures for calibrating, inspecting, and checking automated, mechanical, and electronic equipment.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength, composition and limits on contamination that may adulterate or that may lead to adulteration of the dietary supplement.

    • Written procedures - product complaint (21 CFR 111.553)

      You did not follow written procedures for the requirements to review and investigate a product complaint.

    • Quality control, review, approve; investigate, follow-up (21 CFR 111.560(b))

      Your quality control personnel did not review and approve the findings and follow-up action of an investigation.

    • Record - product complaint; batch, lot, control number (21 CFR 111.570(b)(2)(ii)(B))

      The written record of a product complaint did not include the batch, lot, or control number of the dietary supplement.

    • Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))

      The written record of a product complaint did not include the findings of the investigation and follow-up action taken.

    FEI 3008281246

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What Mineralife Nutraceuticals, LLC says it offers

From Mineralife Nutraceuticals, LLC’s own website, checked . Not verified by us.

Products

  • Herbal & botanicalShow quote“Herbal, glycerin, oil-based, and liposomal fills from 1 oz through 64 oz in glass dropper bottles, PET, and HDPE.”
    “Herbal, glycerin, oil-based, and liposomal fills from 1 oz through 64 oz in glass dropper bottles, PET, and HDPE.”

    Source page · seen on

  • Electrolytes & hydrationShow quote“Electrolytes for Sport”
    “Electrolytes for Sport”

    Source page · seen on

Services

  • Custom formulationShow quote“Mineralife can support formulation, sourcing, manufacturing, packaging, and shipment to a distribution facility”
    “Mineralife can support formulation, sourcing, manufacturing, packaging, and shipment to a distribution facility”

    Source page · seen on

  • Packaging & bottlingShow quote“Mineralife takes that locked scope and runs filling, packaging and labeling.”
    “Mineralife takes that locked scope and runs filling, packaging and labeling.”

    Source page · seen on

We read the company’s public web pages and keep a claim only when its quote appears on the page. A claim is hidden once we haven’t seen it for 120 days. Spotted something wrong? Tell us · How we collect website claims

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 2 facility addresses
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.
  • What the company’s own website says it makes and offers, shown above with quotes

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026